TY - JOUR
T1 - A clinical study of glottic carcinoma
AU - Miyano, Kazuki
AU - Ando, Mizuo
AU - Yoshida, Masafumi
AU - Ebihara, Yasuhiro
AU - Asakage, Takahiro
AU - Terahara, Atsuro
AU - Miyano, Kazuki
PY - 2010
Y1 - 2010
N2 - A clinical study was made of 179 patients with previously untreated glottic carcinoma registered in our department between 1998 and 2004. In our facility, T1 glottic cancer was treated by radiotherapy, T2 glottic cancer by radiotherapy or chemoradiotherapy using low-dose CDDP, and T3 and T4 glottic cancer by laryngectomy. The five-year cause-specific survival rate for glottic carcinoma was 95.1%, 96.5% for stage I, 96.6% for stage II, 92.9% for stage III, and 68.6% for stage IV. The five-year local control rate for early glottic carcinoma treated by radiotherapy was 83.1% for T1a, 60.7% for T1b, and 62.5% for T2. In T2 cases, the local control rate was 49.2% for treatment by radiotherapy, and 83.6% for low-dose CDDP with radiotherapy. Low-dose CDDP with radiotherapy contributes to high local control rate in T2 cases.
AB - A clinical study was made of 179 patients with previously untreated glottic carcinoma registered in our department between 1998 and 2004. In our facility, T1 glottic cancer was treated by radiotherapy, T2 glottic cancer by radiotherapy or chemoradiotherapy using low-dose CDDP, and T3 and T4 glottic cancer by laryngectomy. The five-year cause-specific survival rate for glottic carcinoma was 95.1%, 96.5% for stage I, 96.6% for stage II, 92.9% for stage III, and 68.6% for stage IV. The five-year local control rate for early glottic carcinoma treated by radiotherapy was 83.1% for T1a, 60.7% for T1b, and 62.5% for T2. In T2 cases, the local control rate was 49.2% for treatment by radiotherapy, and 83.6% for low-dose CDDP with radiotherapy. Low-dose CDDP with radiotherapy contributes to high local control rate in T2 cases.
KW - Glottic carcinoma
KW - Larynx preservation
KW - Local control
KW - Low dose CDDP
KW - Radiotherapy
UR - http://www.scopus.com/inward/record.url?scp=85009628592&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85009628592&partnerID=8YFLogxK
U2 - 10.5981/jjhnc.36.322
DO - 10.5981/jjhnc.36.322
M3 - Article
AN - SCOPUS:85009628592
VL - 36
SP - 322
EP - 326
JO - Japanese Journal of Head and Neck Cancer
JF - Japanese Journal of Head and Neck Cancer
SN - 1349-5747
IS - 3
ER -